Tolbutamide control of diabetes mellitus

The results of oral therapy tolobutamide in seventy "Type 2" diabetic patients have been studied. Forty-five patients (64 percent) have been well controlled with the drug for periods varying from 5 to 17 months. The drug seems to have had a wider application than described in previous papers. Side-effects were few (Summary)